Published in Anaesthesia on August 01, 1981
Neonatal pulmonary ischemia. I. Clinical and physiological studies. Pediatrics (1967) 3.60
Isolation of disaturated phosphatidylcholine with osmium tetroxide. J Lipid Res (1976) 2.63
Assessment of the risk of the respiratory-distress syndrome by a rapid test for surfactant in amniotic fluid. N Engl J Med (1972) 2.56
Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. J Biol Chem (2001) 2.56
Nucleotide and amino acid sequences of pulmonary surfactant protein SP 18 and evidence for cooperation between SP 18 and SP 28-36 in surfactant lipid adsorption. Proc Natl Acad Sci U S A (1987) 2.43
Kinetics of acetaminophen absorption and gastric emptying in man. Clin Pharmacol Ther (1978) 2.41
Narcotic analgesics and delayed gastric emptying during labour. Lancet (1975) 2.24
Inhibition of gastric emptying and drug absorption by narcotic analgesics. Br J Clin Pharmacol (1975) 2.18
Surface active materials from dog lung. II. Composition and physiological correlations. Am J Physiol (1972) 2.03
Surfactant apoprotein Mr = 26,000-36,000 enhances uptake of liposomes by type II cells. J Biol Chem (1987) 1.88
Direct determination of surface tension in the lung. Proc Natl Acad Sci U S A (1976) 1.83
Functions of the alveolar lining. Am Rev Respir Dis (1977) 1.81
Drugs, diseases and altered gastric emptying. Clin Pharmacokinet (1976) 1.77
Absorption, distribution and elimination of mexiletine. Postgrad Med J (1977) 1.74
Adverse effects of opioid analgesic drugs. Br J Anaesth (1987) 1.72
Pharmacokinetics and analgesic effects of i.m. and oral ketamine. Br J Anaesth (1981) 1.71
Alveolar lining layer is thin and continuous: low-temperature scanning electron microscopy of rat lung. J Appl Physiol (1985) (1995) 1.61
Metabolism and turnover of lung surfactant. Am Rev Respir Dis (1987) 1.56
Pulmonary surfactant and its apoproteins. J Clin Invest (1990) 1.55
Clinical pharmacokinetics of paracetamol. Clin Pharmacokinet (1982) 1.54
Hypoxaemia during outpatient dental anaesthesia. Anaesthesia (1989) 1.50
Isolation of apoproteins from canine surface active material. Am J Physiol (1973) 1.49
Evaluation of pressure-driven captive bubble surfactometer. J Appl Physiol (1985) (1994) 1.48
Pulmonary surface film stability and composition. J Appl Physiol Respir Environ Exerc Physiol (1979) 1.48
Ontogeny of tracheal fluid, pulmonary surfactant, and plasma corticoids in the fetal lamb. J Appl Physiol (1975) 1.41
Subfractionation of lung surfactant. Implications for metabolism and surface activity. Biochim Biophys Acta (1983) 1.40
Simplified radioimmunoassay for serum aldosterone utilizing increased antibody specificity. J Clin Endocrinol Metab (1974) 1.40
A model to test the potency of inhalation anaesthetics. Br J Anaesth (1989) 1.39
Paracetamol and aspirin absorption from Safapryn and Safapryn-Co. Br J Clin Pharmacol (1979) 1.39
Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript. Hum Genet (2011) 1.32
Low molecular weight human pulmonary surfactant protein (SP5): isolation, characterization, and cDNA and amino acid sequences. Proc Natl Acad Sci U S A (1987) 1.31
Rates of replacement of lecithins and alveolar instability in rat lungs. Am J Physiol (1967) 1.29
Direct determination of volume- and time-dependence of alveolar surface tension in excised lungs. Proc Natl Acad Sci U S A (1978) 1.29
Enhancement of oxygen toxicity by the herbicide paraquat. Am Rev Respir Dis (1973) 1.28
Novel association of a diverse range of genes with renal cell carcinoma as identified by differential display. Int J Cancer (2000) 1.28
Surface active materials from dog lung. I. Method of isolation. Am J Physiol (1972) 1.26
Lung surfactant proteins, SP-B and SP-C, alter the thermodynamic properties of phospholipid membranes: a differential calorimetry study. Biochemistry (1993) 1.25
Alveolar subphase pH in the lungs of anesthetized rabbits. Proc Natl Acad Sci U S A (1981) 1.25
Isolation and properties of type II alveolar cells from rat lung. Am Rev Respir Dis (1977) 1.24
Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans. J Pharm Sci (1982) 1.18
Pro-opiomelanocortin messenger ribonucleic acid and posttranslational processing of beta endorphin in spleen macrophages. J Clin Invest (1986) 1.17
Studies of the structure of lung surfactant protein SP-A. Am J Physiol (1989) 1.16
Concurrent drug therapy in patients undergoing surgery. Anaesthesia (1987) 1.16
Measurement of FEV1 and FVC. Comparison of a pocket spirometer with the Vitalograph. Anaesthesia (1988) 1.15
Protein composition of rabbit alveolar surfactant subfractions. Biochim Biophys Acta (1984) 1.14
The role of sulphate conjugation in the metabolism and disposition of oral and intravenous paracetamol in man. Br J Clin Pharmacol (1984) 1.14
Ventilation enhances pulmonary alveolar clearance of radioactive dipalmitoyl phosphatidylcholine in liposomes. Am Rev Respir Dis (1980) 1.13
Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease. Pediatrics (1991) 1.13
Effect of induction of anaesthesia with etomidate on corticosteroid synthesis in man. Br J Anaesth (1985) 1.13
Control of lung surfactant by ventilation, adrenergic mediators, and prostaglandins in the rabbit. Am Rev Respir Dis (1978) 1.12
Pharmacokinetics of propofol (diprivan) in elderly patients. Br J Anaesth (1988) 1.12
Pharmacokinetics and analgesic effect of ketamine in man. Br J Anaesth (1981) 1.09
Effect of anaesthesia on gastric motility and emptying. Br J Anaesth (1984) 1.09
Paracetamol absorption from Paramax, Panadol and Solpadeine. Br J Clin Pharmacol (1983) 1.08
Studies on human sexual development. III. Fetal pituitary and serum, and amniotic fluid concentrations of LH, CG, and FSH. J Clin Endocrinol Metab (1976) 1.06
Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells. Endocr Relat Cancer (2005) 1.06
Characterization of a novel gene, STAG1/PMEPA1, upregulated in renal cell carcinoma and other solid tumors. Mol Carcinog (2001) 1.05
Surface active materials from dog lung. 3. Thermal analysis. Am J Physiol (1972) 1.05
Effect of cisapride on morphine-induced delay in gastric emptying. Br J Anaesth (1987) 1.04
Nonionic polymers reverse inactivation of surfactant by meconium and other substances. Am J Respir Crit Care Med (1999) 1.04
Polymer-surfactant treatment of meconium-induced acute lung injury. Am J Respir Crit Care Med (2000) 1.03
Ketamine disposition in children and adults. Br J Anaesth (1983) 1.03
Data point weighting in pharmacokinetic analysis: intravenous paracetamol in man. J Pharm Pharmacol (1976) 1.01
Effect of different rates of infusion of propofol for induction of anaesthesia in elderly patients. Br J Anaesth (1990) 1.01
Gastric emptying and drug absorption before surgery. Br J Anaesth (1984) 1.01
Surfactant in the lung and tracheal fluid of the fetal lamb and acceleration of its appearance by dexamethasone. Pediatrics (1975) 1.00
Comparative lipid chemistry of lungs. Arch Intern Med (1971) 0.99
Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumours. Br J Cancer (1998) 0.99
Comparison of captive and pulsating bubble surfactometers with use of lung surfactants. J Appl Physiol (1985) (1994) 0.99
Pulmonary surfactant. Am Rev Respir Dis (1970) 0.99
Gastric contents at induction of anaesthesia. Is a 4-hour fast necessary? Br J Anaesth (1983) 0.98
Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4. J Biol Chem (2000) 0.97
Ventilatory and cholinergic control of pulmonary surfactant in the rabbit. J Appl Physiol Respir Environ Exerc Physiol (1977) 0.97
Surface activity of rabbit pulmonary surfactant subfractions at different concentrations in a captive bubble. J Appl Physiol (1985) (1994) 0.97
Repeated-dose pharmacodynamics of clopidogrel in healthy subjects. Semin Thromb Hemost (1999) 0.97
Effects of a protein-free, synthetic surfactant on survival and pulmonary function in preterm lambs. J Pediatr (1985) 0.96
Polyethylene glycol/surfactant mixtures improve lung function after HCl and endotoxin lung injuries. Am J Respir Crit Care Med (2001) 0.94
Surfactant release in excised rat lung is stimulated by air inflation. J Appl Physiol Respir Environ Exerc Physiol (1981) 0.94
Dispersal of rabbit lung into individual viable cells: a new model for the study of lung metabolism. Science (1972) 0.94
Stimulation of breathing movements in fetal sheep by inhibitors of prostaglandin synthesis. J Dev Physiol (1979) 0.94
Pulmonary and circulatory effects of fibrinopeptides. Circ Res (1967) 0.93
TTYH2, a human homologue of the Drosophila melanogaster gene tweety, is located on 17q24 and upregulated in renal cell carcinoma. Genomics (2001) 0.93
Premedication for upper gastrointestinal endoscopy: a comparative study of flunitrazepam, diazepam and neuroleptanalgesia. Endoscopy (1978) 0.93
Pulmonary effects of the herbicide paraquat studied 3 days after injection in rats. J Appl Physiol (1973) 0.92
Tracheal fluid in fetal lambs: spontaneous decrease prior to birth. J Appl Physiol Respir Environ Exerc Physiol (1979) 0.92
Coffee contains potent opiate receptor binding activity. Nature (1983) 0.92
Pulmonary surfactant and evolution of the lungs. Science (1970) 0.92
Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas. Clin Cancer Res (2001) 0.92
Pulmonary surfactant therapy. West J Med (1995) 0.92
Lung function in prematurely delivered rabbits treated with a synthetic surfactant. Am Rev Respir Dis (1987) 0.91
The disposition of intravenous doxapram in man. Eur J Clin Pharmacol (1979) 0.90
A common nomenclature for members of the tissue (glandular) kallikrein gene families. Agents Actions Suppl (1992) 0.90
Relief of pain by infusion of morphine after operation: does tolerance develop? Br Med J (Clin Res Ed) (1985) 0.90
The radioimmunoassay of pulmonary surface active material in sheep lung. Am Rev Respir Dis (1974) 0.90
Mechanism of compliance change in excised rat lungs at low transpulmonary pressure. J Appl Physiol (1970) 0.89